Please use this identifier to cite or link to this item: http://buratest.brunel.ac.uk/handle/2438/13759
Title: A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma
Authors: Dvorkina, M
Nieddu, V
Chakelam, S
Pezzolo, A
Cantilena, S
Leite, AP
Chayka, O
Regad, T
Pistorio, A
Sementa, AR
Virasami, A
Barton, J
Montano, X
Lechertier, T
Brindle, N
Morgenstern, D
LE Bras, M
Burns, A
Saunders, N
Hodivala-Dilke, K
Bagella, L
de The, H
Anderson, J
Sebire, N
Pistoia, V
Sala, A
Salomoni, P
Issue Date: 2016
Publisher: American Association for Cancer Research
Citation: Clinical cancer research : an official journal of the American Association for Cancer Research, 22(13): pp. 3398–3409, (2016)
Abstract: Neuroblastoma is a childhood malignancy originating from the sympathetic nervous system with a complex biology, prone to metastasize and relapse. High-risk, metastatic cases are explained in part by amplification or mutation of oncogenes such as MYCN and ALK and loss of tumour suppressor genes in chromosome band 1p. However, it is fundamental to identify other pathways responsible for the large portion of neuroblastomas with no obvious molecular alterations.Neuroblastoma cell lines were used for assessment of tumour growth in vivo and in vitro. Protein expression in tissues and cells was assessed using immunofluorescence and immunohistochemistry. The association of PML expression with neuroblastoma outcome and relapse was calculated using log-rank and Mann-Whitney tests, respectively. Gene expression was assessed using chip microarrays.PML is detected in the developing and adult sympathetic nervous system, whereas it is not expressed or low in metastatic neuroblastoma tumours. Reduced PML expression in patients with low-risk cancers - i.e. localized and negative for the MYCN protooncogene - is strongly associated with tumour recurrence. PML-I, but not PML-IV, isoform suppresses angiogenesis via upregulation of thrombospondin-2 (TSP-2), a key inhibitor of angiogenesis. Finally, PML-I and TSP-2 expression inversely correlates with tumour angiogenesis and recurrence in localized neuroblastomas.Our work reveals a novel PML-I-TSP2 axis for regulation of angiogenesis and cancer relapse, which could be used to identify patients with low-risk, localized tumours that might benefit from chemotherapy.
URI: http://bura.brunel.ac.uk/handle/2438/13759
DOI: http://dx.doi.org/10.1158/1078-0432.CCR-15-2081
ISSN: 1078-0432
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.docx162.68 kBUnknownView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.